Triple negative breast cancer (BC) is an aggressive, poor-prognosis of breast cancer for which a clear clinical need exist...
Upcoming SlideShare
Loading in …5
×

Art Of Breast Cancer

666 views
614 views

Published on

ART3, frequently overexpressed in triple negative breast cancer, is a novel diagnostic marker candidate for aggressive, poor prognosis breast cancer

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
666
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
14
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Art Of Breast Cancer

  1. 1. Triple negative breast cancer (BC) is an aggressive, poor-prognosis of breast cancer for which a clear clinical need exists because this sub-type of BC is refractory to hormone-therapy and herceptin.<br />Meta-analysis of 3 independent breast cancer data sets demonstrates that triple negative breast cancer, which does not express the traditional markers of BC including ESR, PGR, and Her2/Neu, contains significantly elevated levels of ART3 mRNA. Hence, ART3 is a novel candidate marker for triple negative BC.<br />No previously published data about ART3 in triple negative breast cancer exist. I carried out the current BC meta-analysis on data produced by unrelated whole-genome expression technologies. I did so in order to reduce the chance of technology-specific errors. Please use the GEO IDs in the above table to find the specific data sources at GEO website.<br />-MehisPold, M.D.<br />E-mail: mehisp@hotmail.com<br />Copyright © Eomix, Inc.<br />

×